Filana Therapeutics (SAVA) Q4 2023 Earnings

28FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.77
-0.68
-0.59
-0.5

Details

Expected EPS
-0.52
Actual EPS
-0.5
Surprise EPS
0.02
Surprise Percent
+3.85%

Description

Filana Therapeutics (SAVA) has reported earnings of -0.5 per share for Q4 2023.

0 Comments

Share your thoughts